A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Across trials, there was an average weight loss of around 15 to 17 percent after 68 weeks of treatment. Since Wegovy is prescribed in higher doses, it can be more effective than Ozempic for weight ...

Clinical trials demonstrated that patients lost an average of 10%–15% of their body weight over time. This led to widespread off-label prescribing of Ozempic for people without diabetes seeking ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

It said Novo Nordisk had access to information dating back as early as its Ozempic clinical trials that identified cases of NAION yet chose not to list the condition on its warning label.

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.

Suddenly, GLP-1 drugs like Ozempic, Wegovy and Mounjaro are everywhere, promising rapid weight loss by blunting appetite and ...